0,756  0,007  Chemopreventive
0,743  0,005  NOS2 expression inhibitor
0,742  0,004  Monophenol monooxygenase inhibitor
0,725  0,015  Antineoplastic (lung cancer)
0,696  0,004  Skin whitener
0,675  0,005  Antiprotozoal (Leishmania)
0,671  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,695  0,032  Antiinflammatory
0,644  0,009  Antioxidant
0,642  0,007  Cardioprotectant
0,642  0,018  15-Lipoxygenase inhibitor
0,625  0,008  Lipoxygenase inhibitor
0,654  0,038  Apoptosis agonist
0,635  0,027  Transcription factor NF kappa B inhibitor
0,616  0,009  AR expression inhibitor
0,609  0,008  Free radical scavenger
0,601  0,013  Spasmolytic
0,588  0,012  NOS3 expression inhibitor
0,565  0,005  Melanin inhibitor
0,561  0,010  Hypoglycemic
0,574  0,039  Antineoplastic (breast cancer)
0,537  0,009  Vasodilator
0,537  0,013  Nitric oxide antagonist
0,548  0,032  Antileukemic
0,524  0,013  CYP1A2 inhibitor
0,515  0,019  Hepatic disorders treatment
0,515  0,022  Antineoplastic (melanoma)
0,496  0,005  Lipid peroxidase inhibitor
0,508  0,020  Cytostatic
0,521  0,037  CYP3A4 substrate
0,493  0,021  UGT1A9 substrate
0,512  0,045  Alzheimer's disease treatment
0,510  0,047  Cyclophilin D inhibitor
0,510  0,047  Antidiabetic
0,483  0,028  Antihypercholesterolemic
0,473  0,023  Antineoplastic (brain cancer)
0,453  0,006  NOS3 expression enhancer
0,456  0,019  Antipyretic
0,448  0,018  Antidiabetic symptomatic
0,450  0,027  Antineoplastic (glioma)
0,450  0,028  Antiosteoporotic
0,428  0,007  Protein-tyrosine phosphatase inhibitor
0,427  0,009  Platelet adhesion inhibitor
0,443  0,030  Antiischemic
0,422  0,009  Topoisomerase II inhibitor
0,417  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,432  0,025  Proliferative diseases treatment
0,438  0,037  Antineoplastic (ovarian cancer)
0,455  0,055  Antibacterial
0,448  0,052  5 Hydroxytryptamine release inhibitor
0,433  0,041  Bone diseases treatment
0,399  0,012  Antihypotensive
0,398  0,025  Antiparasitic
0,376  0,004  Electron transport complex I inhibitor
0,384  0,018  Antihelmintic
0,397  0,032  Antidiabetic (type 2)
0,411  0,051  Antineoplastic (colorectal cancer)
0,380  0,023  UDP-glucuronosyltransferase substrate
0,402  0,050  Antineoplastic (colon cancer)
0,387  0,043  Radioprotector
0,353  0,013  Genotoxic
0,378  0,040  Antineoplastic (cervical cancer)
0,332  0,007  Heat shock protein 90 antagonist
0,375  0,050  ICAM1 expression inhibitor
0,329  0,014  UGT2B15 substrate
0,324  0,011  Heat shock protein 90 alpha antagonist
0,356  0,048  CTGF expression inhibitor
0,356  0,052  Vasodilator, coronary
0,292  0,008  Topoisomerase II alpha inhibitor
0,347  0,063  Streptokinase A inhibitor
0,318  0,034  Antihypertriglyceridemic
0,320  0,039  UGT1A6 substrate
0,321  0,041  Antineoplastic (glioblastoma multiforme)
0,326  0,047  Cytotoxic
0,324  0,052  Antineoplastic (multiple myeloma)
0,317  0,047  Transcription factor STAT inhibitor
0,300  0,030  Hepatoprotectant
0,273  0,007  Estrogen antagonist
0,298  0,032  RNA-directed DNA polymerase inhibitor
0,298  0,033  UGT1A1 substrate
0,332  0,068  Antihypertensive
0,303  0,043  Antimitotic
0,341  0,087  Ulceration
0,266  0,014  5-Lipoxygenase inhibitor
0,296  0,044  Antineoplastic (lymphocytic leukemia)
0,254  0,005  Actinic keratosis treatment
0,273  0,025  UGT1A3 substrate
0,270  0,026  Sepsis treatment
0,340  0,096  Antipruritic, allergic
0,317  0,074  Apoptosis antagonist
0,247  0,006  Estrogen agonist
0,305  0,066  Lipoprotein disorders treatment
0,279  0,041  Peroxidase inhibitor
0,244  0,007  Estrogen receptor beta antagonist
0,260  0,024  Protein kinase stimulant
0,291  0,055  Platelet antagonist
0,334  0,101  Antiprotozoal
0,269  0,035  UGT2B7 substrate
0,292  0,060  DNA damaging
0,309  0,082  Prostate cancer treatment
0,299  0,076  Respiratory analeptic
0,299  0,079  Caspase 3 stimulant
0,329  0,109  Histamine release inhibitor
0,255  0,036  Diabetic retinopathy treatment
0,221  0,004  Ornithine decarboxylase inhibitor
0,223  0,007  Estrogen receptor alpha antagonist
0,295  0,082  CYP3A4 inhibitor
0,281  0,070  UGT2B4 substrate
0,276  0,066  Transcription factor STAT3 inhibitor
0,222  0,012  Beta amyloid protein antagonist
0,217  0,007  Postmenopausal disorders treatment
0,324  0,114  TNF expression inhibitor
0,241  0,032  Antineoplastic (squamous cell carcinoma)
0,239  0,033  Contraceptive
0,349  0,146  Caspase 9 stimulant
0,240  0,045  Pneumotoxic
0,257  0,062  Antineoplastic (sarcoma)
0,266  0,072  Cardiotonic
0,257  0,064  Antineoplastic (lymphoma)
0,220  0,032  Tubulin antagonist
0,199  0,014  Contraceptive female
0,213  0,030  Antidiarrheal
0,199  0,018  Antiemetic
0,275  0,095  12-Lipoxygenase inhibitor
0,253  0,073  Myocardial infarction treatment
0,192  0,012  Papain-like protease (SARS coronavirus) inhibitor
0,228  0,049  CYP2B6 inhibitor
0,291  0,113  CYP2C9 substrate
0,202  0,026  Topoisomerase I inhibitor
0,254  0,081  Chemoprotective
0,198  0,027  Glutathione S-transferase substrate
0,298  0,127  CYP2C19 inhibitor
0,176  0,005  Estrogen receptor beta agonist
0,222  0,057  Neurotrophic factor enhancer
0,255  0,092  GST M1-1 substrate
0,198  0,037  Insulin secretagoues
0,186  0,026  Farnesoid X receptor antagonist
0,279  0,121  Stroke treatment
0,171  0,015  Urease inhibitor
0,233  0,079  Antiamyloidogenic
0,256  0,102  Analeptic
0,223  0,073  Sensitization
0,171  0,024  Bronchodilator
0,170  0,023  Gastritis treatment
0,253  0,107  Antifungal
0,177  0,033  Cholesterol synthesis inhibitor
0,290  0,149  Antiparkinsonian
0,231  0,090  Aldehyde oxidase inhibitor
0,229  0,089  Vascular (periferal) disease treatment
0,187  0,049  Interleukin 6 antagonist
0,235  0,097  5 Hydroxytryptamine uptake stimulant
0,186  0,051  Antiviral (Influenza A)
0,160  0,026  Antineoplastic (uterine cancer)
0,196  0,063  Antipruritic, non-allergic
0,180  0,048  MAO inhibitor
0,244  0,113  Antimycobacterial
0,180  0,050  Interferon gamma antagonist
0,269  0,140  Antiobesity
0,189  0,063  UGT1A4 substrate
0,194  0,068  P-glycoprotein inhibitor
0,180  0,054  Arachidonic acid antagonist
0,269  0,143  CYP2C9 inhibitor
0,161  0,038  Antihemorrhagic
0,176  0,054  Antiischemic, cerebral
0,151  0,031  Antineoplastic antibiotic
0,169  0,048  SULT1A3 substrate
0,181  0,061  Antimutagenic
0,139  0,020  SULT1E1 substrate
0,153  0,035  Ca2+-transporting ATPase inhibitor
0,206  0,089  Hypolipemic
0,195  0,079  Antiarrhythmic
0,128  0,016  Aromatase inhibitor
0,250  0,139  Antiprotozoal (Plasmodium)
0,208  0,100  Cardiovascular analeptic
0,187  0,078  VEGF expression inhibitor
0,176  0,068  Antineoplastic (bone cancer)
0,137  0,028  Prolactin inhibitor
0,253  0,145  Immunosuppressant
0,220  0,113  CYP2C19 substrate
0,165  0,058  Aldose reductase substrate
0,150  0,046  Heat shock protein 70 antagonist
0,130  0,026  Carbonic anhydrase XIII inhibitor
0,114  0,011  Neuraminidase inhibitor
0,207  0,105  Antineoplastic (renal cancer)
0,109  0,007  Potassium channel Kv1.3 blocker
0,175  0,075  Antirickettsial
0,153  0,053  Acetylcholinesterase inhibitor
0,266  0,169  Analgesic
0,116  0,021  HIV-1 integrase (3'-Processing) inhibitor
0,181  0,087  Antiviral (Influenza)
0,122  0,028  NAD(P)H dehydrogenase (quinone) inhibitor
0,124  0,032  Alcohol dehydrogenase inhibitor
0,175  0,083  Carcinogenic
0,113  0,024  Keratolytic
0,209  0,120  Tyrosine 3 hydroxylase inhibitor
0,117  0,030  Phosphodiesterase 4D inhibitor
0,117  0,031  Antiviral (Rhinovirus)
0,195  0,110  Antineoplastic (non-small cell lung cancer)
0,108  0,024  Na+ K+ transporting ATPase inhibitor
0,181  0,098  Histone acetyltransferase inhibitor
0,175  0,093  Abortion inducer
0,166  0,085  Succinate dehydrogenase inhibitor
0,160  0,079  Prostatic (benign) hyperplasia treatment
0,186  0,107  Antiviral (HIV)
0,175  0,097  Pyruvate kinase inhibitor
0,120  0,043  Dementia treatment
0,152  0,075  UGT2B9 substrate
0,171  0,095  Non-steroidal antiinflammatory agent
0,116  0,042  Vascular dementia treatment
0,150  0,076  Cholinergic
0,097  0,024  HIV-1 integrase (Strand Transfer) inhibitor
0,125  0,052  SULT1A1 substrate
0,104  0,031  Antiprotozoal activity enhancer
0,154  0,084  Mutagenic
0,225  0,156  Sodium/bile acid cotransporter inhibitor
0,094  0,029  SULT1A2 substrate
0,124  0,059  Antiviral (Influenza B)
0,093  0,029  HIV-1 integrase inhibitor
0,112  0,048  Anabolic
0,120  0,058  Cystathionine beta-synthase inhibitor
0,069  0,006  Liver X receptor antagonist
0,068  0,007  Retinoic acid alpha receptor agonist
0,092  0,032  Lipase inhibitor
0,105  0,051  UGT2B11 substrate
0,158  0,106  Antimigraine
0,145  0,094  Mcl-1 antagonist
0,175  0,124  VCAM1 expression inhibitor
0,164  0,114  Angiogenesis stimulant
0,156  0,107  Antiviral (Hepatitis)
0,082  0,034  Secretase beta inhibitor
0,124  0,076  Cyclooxygenase 1 inhibitor
0,099  0,052  Bile acid receptor antagonist
0,127  0,084  Psychosexual dysfunction treatment
0,082  0,039  Peroxisome proliferator-activated receptor gamma agonist
0,048  0,006  Estrogen-related receptor beta antagonist
0,226  0,184  Antineoplastic (small cell lung cancer)
0,103  0,062  Gastric antisecretory
0,096  0,056  ABCA1 expression enhancer
0,147  0,107  UGT2B10 substrate
0,119  0,080  Antihyperlipoproteinemic
0,133  0,095  Adenylate cyclase stimulant
0,090  0,054  Contraceptive male
0,073  0,038  SULT2A1 substrate
0,070  0,035  Neuraminidase (influenza) inhibitor
0,072  0,039  Glutamate (mGluR7) antagonist
0,063  0,031  Aldose reductase inhibitor
0,095  0,065  Xanthine oxidase inhibitor
0,061  0,032  Postcoital contraceptive
0,110  0,081  Antiviral (Hepatitis B)
0,077  0,049  Antitreponemal
0,047  0,019  Retinoid X receptor agonist
0,177  0,150  Antituberculosic
0,216  0,190  Calcium channel activator
0,132  0,107  MAP kinase kinase 4 inhibitor
0,062  0,038  Androgen agonist
0,067  0,043  Leukotriene antagonist
0,045  0,022  Dopamine D5 agonist
0,043  0,020  Estrogen receptor alpha agonist
0,118  0,096  Antineoplastic (carcinoma)
0,127  0,106  Antifungal (Cryptococcus)
0,064  0,043  Transcription factor RelA inhibitor
0,133  0,113  Prostate disorders treatment
0,083  0,062  mTOR complex 2 inhibitor
0,091  0,071  Creatine kinase inhibitor
0,096  0,077  Beta glucuronidase inhibitor
0,089  0,071  Butyrylcholinesterase inhibitor
0,056  0,039  Leukotriene C antagonist
0,030  0,013  Sodium/glucose cotransporter 2 inhibitor
0,120  0,104  Diuretic
0,061  0,046  5 Hydroxytryptamine 2A agonist
0,133  0,118  Antipruritic
0,056  0,043  Plasminogen activator inhibitor
0,023  0,011  Retinoic acid alpha receptor antagonist
0,054  0,043  Fatty acid synthase inhibitor
0,064  0,054  Glutamate (mGluR6) antagonist
0,185  0,176  CYP1A2 substrate
0,016  0,008  Antibiotic Tetracycline-like
0,096  0,088  CDC-like kinase 3 inhibitor
0,048  0,040  Potassium channel (Inward rectifier) activator
0,081  0,074  MAO B inhibitor
0,207  0,199  GABA C receptor rho-3 antagonist
0,128  0,121  Antianginal
0,043  0,036  Adenylate cyclase 1 inhibitor
0,076  0,070  Androgen antagonist
0,046  0,039  Potassium channel (ATP-sensitive) activator
0,086  0,080  Alpha 2c adrenoreceptor antagonist
0,135  0,130  Lipocortins synthesis antagonist
0,025  0,020  Sodium/glucose cotransporter inhibitor
0,166  0,162  Nitric-oxide synthase stimulant
0,021  0,019  Retinoic acid receptor agonist
0,081  0,079  Thioredoxin inhibitor
0,090  0,088  UGT2B1 substrate
0,022  0,020  Protein 30S ribosomal subunit inhibitor
0,079  0,078  Potassium channel activator
0,129  0,128  Carcinogenic, group 1

